- Titre
- GNS561, A NEW ORAL CLINICAL-STAGE SMALL MOLECULE COMBINED WITH ANTI-PD1 SHOWED REMARKABLE ANTI-TUMOR EFFECTS IN A TRANSGENIC IMMUNOCOMPETENT HEPATOCELLULAR CARCINOMA MOUSE MODEL (ASV-B)
- Créateurs - sans rôle
- Rachid, MadaniTijeras-Raballand, AnnemilaiCindy Serdjebi - Centre de Recherches en Oncologie biologique et OncopharmacologieSonia Brun - Université de Montpellier, Institut de Recherche en Infectiologie de Montpellier - IRIMChristelle AnsaldiEric RaymondPhilippe Halfon - Hôpital Européen
- Détails de publication
- HEPATOLOGY, Vol.70(Supplement: 1)
- Colloque
- Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting (Boston, MA, United States, 11/2019)
- Identifiants
- 99151977709311
- Unité académique
- Institut de Recherche en Infectiologie de Montpellier - IRIM
- Langue
- English
- Type de ressource
- Conference proceeding
- Champs locaux
- hal-02466433
Acte de colloque
GNS561, A NEW ORAL CLINICAL-STAGE SMALL MOLECULE COMBINED WITH ANTI-PD1 SHOWED REMARKABLE ANTI-TUMOR EFFECTS IN A TRANSGENIC IMMUNOCOMPETENT HEPATOCELLULAR CARCINOMA MOUSE MODEL (ASV-B)
HEPATOLOGY, Vol.70(Supplement: 1)
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting (Boston, MA, United States, 11/2019)
Indicateurs
1 Consultations de la notice